iPACK for Post-op Pain Following ACL Reconstruction
Studying the Effects of iPACK Blocks With Adductor Canal Blocks for Postoperative Analgesia Following ACL Reconstruction
1 other identifier
interventional
82
1 country
1
Brief Summary
This study will consist of patients 12 years and older undergoing ACL reconstruction using a quadriceps or bone-patella tendon bone (BTB) graft. The patients will be randomized to adductor canal block alone, or adductor canal block + iPACK block. The primary goal will be to determine the differences in postoperative pain during the first 72 hours when comparing the two groups. Secondary outcomes will include opioid utilization during the first 72 hours postoperatively and range of motion including terminal knee extension at postoperative follow-up visits.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Aug 2022
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 27, 2022
CompletedFirst Posted
Study publicly available on registry
August 12, 2022
CompletedStudy Start
First participant enrolled
August 25, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 3, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 14, 2023
CompletedResults Posted
Study results publicly available
July 10, 2024
CompletedOctober 16, 2024
October 1, 2024
10 months
July 27, 2022
April 5, 2024
October 3, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pain Scores
The primary endpoint will measure subjective pain scores using a Visual Analog Scale ranging from 0 (no pain) to 100 (severe intolerable pain) at 12-hour intervals during the first 72 hours of the postoperative window. A higher score means worse outcome.
0-72 hours post op
Secondary Outcomes (2)
Total Postoperative Opioid Consumption (Total MME)
up to 72 hours post-op
Range of Motion (Degrees)
up to two months after surgery
Study Arms (2)
Adductor Canal Block (ACB) Only
ACTIVE COMPARATORParticipants randomized to the ACB only group will receive an adductor canal block alone.
ACB + iPACK
ACTIVE COMPARATORParticipants randomized to the ACB + iPACK group will receive both the ACB and iPACK block.
Interventions
Patients will receive an ACB with lidocaine skin wheal
Patients will receive an ACB with iPACK block
Eligibility Criteria
You may qualify if:
- Age 12 years and older
- Patients who are scheduled to undergo an ACL reconstruction with quadriceps or BTB graft.
You may not qualify if:
- Any contraindication to receiving regional anesthesia. This may include infection at the site of injection, allergy to local anesthetic, or pre-existing nerve injury.
- Patients undergoing hamstring graft or allograft for ACL
- Pre-existing infection at the site of injury
- Patients on chronic opioid treatments
- Pre-existing sensory or motor deficit in operative extremity
- Patients having a revision of previous ACL reconstruction
- Pregnant and/or lactating women
- Weighs less than 40kg
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Medical University of South Carolina
Charleston, South Carolina, 29425, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Carey Brewbaker
- Organization
- Medical University of South Carolina
Study Officials
- PRINCIPAL INVESTIGATOR
Carey Breabaker, MD
Medical University of South Carolina
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Only the patient will be blinded to the treatment group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
July 27, 2022
First Posted
August 12, 2022
Study Start
August 25, 2022
Primary Completion
July 3, 2023
Study Completion
August 14, 2023
Last Updated
October 16, 2024
Results First Posted
July 10, 2024
Record last verified: 2024-10